
1. science. 2013 sep 20;341(6152):1387-90. doi: 10.1126/science.1241475. epub 2013
sep 12.

structure ccr5 chemokine receptor-hiv entry inhibitor maraviroc complex.

tan q(1), zhu y, li j, chen z, han gw, kufareva i, li t, l, fenalti g, li j,
zhang w, xie x, yang h, jiang h, cherezov v, liu h, stevens rc, zhao q, wu b.

author information: 
(1)cas key laboratory receptor research, shanghai institute materia medica,
chinese academy sciences, 555 zuchongzhi road, pudong, shanghai, china 201203.

comment in
    science. 2013 sep 20;341(6152):1347-8.

the ccr5 chemokine receptor acts co-receptor hiv-1 viral entry. 
report 2.7 angstrom-resolution crystal structure human ccr5 bound the
marketed hiv drug maraviroc. structure reveals ligand-binding site 
distinct proposed major recognition sites chemokines viral
glycoprotein gp120, providing insights mechanism allosteric
inhibition chemokine signaling viral entry. comparison ccr5 
cxcr4 crystal structures, along models co-receptor-gp120-v3 complexes,
suggests different charge distributions steric hindrances caused by
residue substitutions may major determinants hiv-1 co-receptor selectivity.
these high-resolution insights ccr5 enable structure-based drug
discovery treatment hiv-1 infection.

doi: 10.1126/science.1241475 
pmcid: pmc3819204
pmid: 24030490  [indexed medline]

